Summary & Overview
HCPCS Q4429: Dermabind Chemical Skin Adhesive, Per Square Centimeter
HCPCS Level II code Q4429 denotes Dermabind chemical (or Dermabind chemical X) applied per square centimeter as an add-on to a primary procedure. The code captures area-based application of a topical skin adhesive or chemical dressing used to close or protect wounds following a primary surgical or procedural intervention. Nationally, accurate use of add-on HCPCS codes like Q4429 affects claims processing, bundling decisions, and clinical documentation for wound care procedures across ambulatory and emergency settings.
Key payers addressed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code’s clinical context and service settings, plus what to expect in payer coverage approaches and documentation requirements. The publication outlines typical billing contexts where Q4429 is appended to a primary procedure, common site-of-service implications for outpatient surgery and wound clinics, and the role of per-square-centimeter measurement in determining units billed.
This summary prepares providers, billers, and policy analysts to interpret Q4429 in claims workflows, coding audits, and payer communications. Data not available in the input is noted where applicable in detailed sections that follow.
Billing Code Overview
HCPCS Level II code Q4429 describes Dermabind chemical or Dermabind chemical X applied per square centimeter as an add-on, billable in addition to a primary procedure. The code represents a topical or adhesive chemical dressing application measured by area treated (per square centimeter).
Service type: Topical wound dressing / skin adhesive application
Typical site of service: Outpatient surgical settings, wound care clinics, emergency departments, and other ambulatory care sites where a primary procedure is performed and an adjunct chemical skin closure or dressing is applied.
Clinical & Coding Specifications
Clinical Context
A 34-year-old male presents to an outpatient dermatology clinic after sustaining a 3-cm laceration to the forearm from a kitchen knife. The wound is clean, with superficial to partial-thickness skin loss and edges that do not approximate well. The dermatologist elects to apply a topical tissue adhesive matrix product, billed as Q4429 (Dermabind per square centimeter), as an adjunct to primary closure techniques to reinforce epidermal adhesion and reduce scarring. The clinical workflow includes wound assessment, local anesthesia if needed, primary wound cleansing and debridement, approximate closure with sutures or staples when indicated, measurement of the area to be covered with the dermabind product, application of the product per manufacturer instructions, and documented square centimeters used for billing.
Typical site of service is an outpatient clinic or ambulatory surgical center. The typical patient scenario includes superficial lacerations, partial-thickness skin avulsions, or graft/dermal matrix reinforcement where an add-on dermal adhesive or matrix product is applied over or beneath a primary closure.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management service by the same physician on the day of a procedure | Use when a distinct E/M visit is performed in addition to the procedure involving . |